Where L-valine is permitted, and what the file must show
L-valine is used as a food supplement ingredient in the EU, the US and the UK, but no single permission covers all three. The EU has no harmonised positive list for amino acids, the US regulates it as a dietary ingredient, and the UK applies retained law. The file must show the form, the market, the contaminant data, the label and the claim boundary.
Permission, contaminant limits, label wording and claims are four separate questions, and the EU, US and UK answer them with different instruments.
The four checks
Four questions decide whether a lot can be sold: is the ingredient permitted in that market and form; does the finished product stay under the contaminant limits; does the label name the ingredient and amount correctly; and is any claim authorised and substantiated? A batch certificate supports all four and replaces none.
The operator placing the product on the market owns the file; a supplier's certificate is an input, not a defence. This is a sourcing reference, not legal advice.
European Union
Directive 2002/46/EC harmonises food supplements, but its Annex II positive list covers vitamins and minerals, not amino acids. L-valine sits under general food law, Regulation (EC) No 178/2002, and any national rules the destination Member State applies. It has a history of use before 15 May 1997; confirm its current entry in the EU Novel Food Catalogue for the specific form and any national restriction.
There is no harmonised maximum level for valine, and some Member States apply their own notification or composition rules. The supplement particulars come from Directive 2002/46/EC, and the general labelling rules from Regulation (EU) No 1169/2011. A BCAA blend is three amino acids, each permitted and declared; the ratio does not create a new ingredient.
Regulation (EU) 2023/915, which applies from 25 May 2023, replaced Regulation (EC) No 1881/2006. Its limits apply to the product as sold, not to the drum, so a raw-material specification needs headroom for the finished dose and method uncertainty.
United States
L-valine is a dietary ingredient under DSHEA. The supplier should support that it was marketed in the US before 15 October 1994; such an ingredient does not need a new dietary ingredient notification. The product is made under 21 CFR 111 and labelled under 21 CFR 101.36. The FDA does not approve supplements before sale, so the file is the evidence.
A structure/function claim is allowed if truthful, accurate and substantiated, with the DSHEA disclaimer in 21 CFR 101.93 and an FDA notification within 30 days of marketing. A disease claim is outside that route, and advertising is subject to FTC substantiation.
In a BCAA blend, each amino acid is a dietary ingredient; the Supplement Facts panel should identify each one and its amount. A proprietary-blend format has its own rules in 21 CFR 101.36, so check the current text.
United Kingdom
The Food Supplements (England) Regulations 2003 list permitted vitamins and minerals; amino acids are not in those schedules, so L-valine sits under general food law and national rules. Wales and Scotland have parallel instruments, and Northern Ireland applies the EU list under the Windsor Framework.
Great Britain retained Regulation (EC) No 1881/2006 as assimilated law rather than adopting Regulation (EU) 2023/915. The limits carried over, and they can be amended by UK instrument, so legislation.gov.uk is the reference. The Food Information Regulations 2014 apply the retained labelling rules, and the GB register lists permitted claims. A label checked against the EU text is not automatically current for Great Britain.
Contaminant limits
| Metal | EU · 2023/915 | US federal | UK retained limits |
|---|---|---|---|
| Lead | 3.0 mg/kg | No numeric federal limit | 3.0 mg/kg |
| Cadmium | 1.0 mg/kg (3.0 for seaweed-based) | No numeric federal limit | 1.0 mg/kg |
| Mercury | 0.10 mg/kg | No numeric federal limit | 0.10 mg/kg |
| Arsenic | No harmonised limit; buyer sets one | No numeric federal limit | No harmonised limit; the buyer sets one |
The catalog limits are Pb ≤3, As ≤2, Cd ≤1 and Hg ≤0.1 mg/kg. Lead, cadmium and mercury sit at or below the EU and UK ceilings; arsenic is a buyer-set limit. The EU and UK figures apply to the food as sold.
US federal law has no numeric ceiling for these metals in supplements; cGMP applies. California's Proposition 65 sets daily exposure levels, including 0.5 µg/day for lead, 4.1 µg/day for cadmium and 10 µg/day for inorganic arsenic, so a dose can require a warning even when no federal limit is broken.
The claim boundary
In the EU and UK, a health claim must be authorised and appear in the applicable Register; Regulation (EC) No 1924/2006 also requires it to be truthful, clear and substantiated. As of this review, neither Register lists an authorised claim for L-valine as such; a BCAA ratio is a formula description, not a claim.
In the US, a structure/function claim is possible under DSHEA with the disclaimer and the notification, but a disease claim is not. In all three markets the claim must describe the product, not a disease, with evidence in the file.
A composition statement such as “99% L-valine” is not a health claim, but it must match the assay and basis. A ratio claim must match the measured amounts, not only the artwork.
The document file
| Document | What it supports | Market |
|---|---|---|
| Batch certificate of analysis | Release against the specification, with methods and results | All |
| Specification | The agreed limits, methods and basis | All |
| Technical and safety data sheets | Solubility, mesh, handling, pack and hazard information | All |
| Allergen, GMO and animal-derived input statements | Composition and labelling declarations | EU, UK, US |
| Novel food or dietary ingredient statement | The market entry position for the form | EU, UK, US |
| Origin and manufacturer statement | Traceability and the source route | All |
| Heavy-metal and micro reports | The contaminant and hygiene envelope | All |
| Packaging and food-contact declaration | The pouch or drum in contact with the powder | EU, UK, US |
The checklist
- Name the form and CAS 72-18-4; a BCAA blend is three ingredients.
- Confirm the market entry position: EU Member State rules, the US pre-1994 basis, the UK retained position.
- Set raw-material limits below the finished ceiling, including an arsenic limit.
- Check the daily dose against the figures and, in the US, Proposition 65 levels.
- Match the label name and amount to the certificate and PO.
- Check every claim against the Register or the DSHEA route.
- Collect documents against the lot number, not the product name.
- Check the Member State notification rule and any Northern Ireland sale.
The release tests behind the file are on the COA page; the form choice is on the grade page; identity evidence is on the identity page. The product hub carries the catalog specification, the market notes are in the EU, US and UK references, and the metals are described in the ICP-MS method note.
Related documents
Send the specification you intend to use — grade, quantity and destination market — and we will reply with the batch COA, the technical data sheet and a quotation.
Request a quotation